GMDA Company Profile and Key Details
Gamida Cell Ltd.
GMDA Stock Price Chart
Stock Price Today
Gamida Cell Ltd. (GMDA) stock remained unchanged at $0.03 a share on NASDAQ. The stock opened at $0.04, fluctuating between $0.03 to $0.04 during the session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. In addition, the company is developing NK cell pipeline comprising GDA-301, GDA-401, GDA-501, and GDA-601 to treat hematologic malignancies and solid tumors. The company was founded in 1998 and is headquartered in Jerusalem, Israel.
Company Information
| Employees | 143 |
| Beta | 1.03 |
| Sales or Revenue | $1.78M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Gamida Cell Ltd. (NASDAQ: GMDA) stock price is $0.03 in the last trading session. During the trading session, GMDA stock reached the peak price of $0.04 while $0.03 was the lowest point it dropped to. The percentage change in GMDA stock occurred in the recent session was 0% while the dollar amount for the price change in GMDA stock was -.
The NASDAQ listed GMDA is part of Biotechnology industry that operates in the broader Healthcare sector. Gamida Cell Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Shai Lankry CPA, M.B.A.
Chief Financial Officer
Ms. Abigail L. Jenkins
Pres, Chief Executive Officer & Director
Ms. Michele Ilene Korfin M.B.A., R.Ph.
Chief Operating & Chief Commercial Officer
Dr. Tracey Lodie Ph.D.
Scientific Advisor & Consultant
Mr. Joshua F. Patterson
Gen. Counsel & Chief Compliance Officer
Mr. Naftali Brikashvili CPA
Senior Vice President Fin. & Operations
Dr. Ronit Simantov M.D.
Chief Medical & Chief Scientific Officer
Heather DiVecchia
Chief of Staff
Mr. Shai Lankry C.P.A., M.B.A.
Executive Officer
Mr. Paul Nee
Vice President of Marketing
Mr. Vladimir Melnikov
Senior Vice President of Global Operations & Manufacturing
Ms. Mary Theresa Coelho M.B.A.
Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer
Ms. Linda Stamler
Vice President of Marketing & Account Management
Ms. Penny Bushell
Chief Human Resource Officer
GMDA's closing price is 308.75% higher than its 52-week low of $0.01 where as its distance from 52-week high of $2.51 is -98.7%.
Number of GMDA employees currently stands at 143.
Official Website of GMDA is: https://www.gamida-cell.com
GMDA could be contacted at phone 972 265 95666 and can also be accessed through its website. GMDA operates from 5 Nahum Heftsadie Street, Jerusalem, 91340, Israel.
GMDA stock volume for the day was 23.04M shares. The average number of GMDA shares traded daily for last 3 months was 9.67M.
The market value of GMDA currently stands at $4.34M with its latest stock price at $0.03 and 132.64M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com